🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 600.0mg (7 products) 📚 39 studies (Tier A: 2, B: 13)
This product: 500mg

Other Ingredients

Hypromellose

Label Claims — Verification

All Other
Structure/Function
All Other (96% of products) Structure/Function (81% of products) Nutrient (19% of products) No Claim (3% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: Take 1 capsule daily or as recommended by your healthcare practitioner.

⚠️ Warnings & Precautions

Warning: Consult with a healthcare practitioner before taking this.

Do not take this if you are pregnant, nursing, or under the age of 18.

Do not take this if you are pregnant, nursing, or under the age of 18.

If you experience adverse reactions from taking this product, discontinue immediately and contact a healthcare practitioner.

Keep out of reach of children

🧪 Formulation Notes

Supports cellular health Precursor to Glutathione

NAC (N-Acetyl-L-Cysteine)

Pure Nootropics NAC is a potent antioxidant that provides defense against free radicals and cellular protection.

Always Non-GMO Preservative free Gluten free

Additional Information

Unlock your potential

Store in a cool, dry place.

Product Details

UPC / SKU 8 54051 00825 2
DSLD Entry Date 2024-08-22
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 316590
Data Updated 2026-04-11

Research Evidence

41 Research Sources
51 Avg Quality Score
19 Rct
13 Meta Analysis
9 Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024
View all evidence for Nac →

Compare Similar Products

View all Nac products →